Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1990-09-10
1992-03-10
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424644, 424646, 424718, 514908, G01N 3315, A61K 3326, A61K 3328, A61K 3300
Patent
active
050948369
ABSTRACT:
There is disclosed a composition and method for detecting the presence of cancer in humans. The method includes contacting a sample of human urine with a composition which reacts with the urine to form a colored precipitate to indicate the presence of cancer. The composition includes mercury, nickel, nitric acid and distilled water, and may further be admixed with a material to form a gel.
REFERENCES:
patent: 3271465 (1966-09-01), Krewer et al.
Kido y et al., "An Improved Method for the Millon Reaction" Chem. Pharm. Bull. 29(8):2296-2302 (1981).
Warren, K. S. et al., "Interfering Ultraviolet-Absorbing Compounds as Sources of Error in Common Clinical Chemistry Tests", Clinical Chemistry 15(12): 1147-1156 (1969).
Y. J. Kim et al., "Sensitivity and Specificity of the Reagent for Cancer Diagnosis Obtained by Urine NMR Measurement", The New Medical Journal, 28(2):51-54 (1985).
Yong J. Kim, "The Study of Possibility of Finding a Reagent for Cancer Diagnosis by Urine NMH Measurement", J. of the Korea Society of Medical & Biological Engineering, 7(1):35-39 (1986).
Manki Park et al., "Development of Reagent for Cancer Diagnosis by Urine Color Reaction (l)-Comparative Analysis of Cancer and Non-Cancer Urine by NMR, HPLC and Gift Reagent", Arch. Pharm. Res., 11(2):134-138 (1988).
Yong-Jin Kim et al., "The Possible Reagents for a Cancer Diagnosis by a Urine Color Reaction", Journal of the Korea Society of Medical and Biological Engineering, 8(2):145-149 (1987).
Hollinden Gary E.
Hollrah Glennon H.
Sam IL Pharmaceutical Manufacturing Co., Ltd.
LandOfFree
Mixed Hg-Ni reagents for screening diagnosis of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mixed Hg-Ni reagents for screening diagnosis of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mixed Hg-Ni reagents for screening diagnosis of cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2283429